Europe Neurovascular Devices Market Size & Outlook
Europe neurovascular devices market, 2018-2030 (US$M)
Related Markets
Europe neurovascular devices market highlights
- The Europe neurovascular devices market generated a revenue of USD 693.3 million in 2023.
- The market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
- Support Devices is the most lucrative device segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 693.3 million |
| Market revenue in 2030 | USD 1,015.7 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Support Devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.0% of the global neurovascular devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,092.8 million by 2030.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 34.86% in 2023. Horizon Databook has segmented the Europe neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for the second-largest market share and is anticipated to grow at a significant rate over the forecast period. Europe is one of the most advanced regions globally with advanced technologies and infrastructure, resulting in significant healthcare facilities and high-quality patient care.
Increasing incidence of acute ischemic stroke, rising adoption of sedentary lifestyle, and introduction of technologically advanced products in the European market are among factors contributing to the growth of neurovascular devices market.
Moreover, increasing geriatric population and rapid technological advancements in reconstruction surgery are expected to further propel the market. Increasing adoption of technologically advanced devices and growing number of CMF surgeries are anticipated to further propel the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe neurovascular devices market size, by country, 2018-2030 (US$M)
Europe Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
